Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Int Immunopharmacol. 2013 Nov 13;18(1):35–42. doi: 10.1016/j.intimp.2013.10.026

FIGURE 3. Effect of allosamidin on oral OVA induced esophageal levels of IL-13, eotaxin-1, and IL-5.

FIGURE 3

The esophagus from mice belonging to three different groups (no OVA; OVA+ diluent; OVA+ allosamidin)(n=12 mice/group) were processed for ELISA to quantitate levels of eotaxin-1(Fig 3A), IL-13 (Fig 3B), and IL-5 (Fig 3C).